Karaman, Y. Et Al. 2024. Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice. The ERS Congress 2024 , (Vienna, Austria), 352.

Karaman, Y., Büber, E., Kurtulan, O., Abohalaka, R., Şahan, Ö. B., Önder, S. Ç., ... Özcan, A.(2024). Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice . The ERS Congress 2024 (pp.352). Vienna, Austria

Karaman, YASEMİN Et Al. "Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice," The ERS Congress 2024 , Vienna, Austria, 2024

Karaman, YASEMİN Et Al. "Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice." The ERS Congress 2024 , Vienna, Austria, pp.352, 2024

Karaman, Y. Et Al. (2024) . "Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice." The ERS Congress 2024 , Vienna, Austria, p.352.

@conferencepaper{conferencepaper, author={YASEMİN KARAMAN Et Al. }, title={Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice}, congress name={The ERS Congress 2024 }, city={Vienna}, country={Austria}, year={2024}, pages={352} }